Nestle and Danone face renewed scrutiny as reports and a French parliamentary review examine infant formula recalls
The Facts
- Nestle and Danone are under renewed scrutiny over how they handled recalls linked to contaminated infant formula.
- The contamination involved cereulide, a toxin that can cause vomiting and diarrhoea and is particularly risky for infants.
- The affected ingredient was supplied by China's CABIO Biotech and was used by several infant formula makers, including Nestle, Danone and Lactalis.
- The recall episode began in December 2025, when Nestle recalled dozens of infant formula batches in about 60 countries over possible cereulide contamination.
- The recalls later widened to include Danone, Lactalis and smaller companies, continuing into February 2026.
- A French parliamentary report published on May 19 said the handling of the case revealed shortcomings by both the French state and manufacturers.
- The parliamentary review said limited resources for control authorities led to growing reliance on manufacturers' own checks, raising questions about oversight and crisis management.
- Some aspects remain unresolved, including the full health impact of the contamination and the extent to which delays in alerts or recalls affected consumers.
Context
What triggered the infant formula recalls?
The recalls were triggered by the detection of cereulide in an ingredient used in infant formula. Multiple reports say the ingredient came from CABIO Biotech in China and was used by several manufacturers, including Nestle, Danone and Lactalis Yahoo! Finance,Reuters,France 24.
Why are Nestle and Danone being examined again now?
New attention followed reports by Radio France, RTBF and RTS questioning how quickly authorities were alerted and recalls were carried out, alongside a French parliamentary report reviewing the broader handling of the crisis Yahoo! Finance,Reuters,Le Monde.
Why does this matter beyond the companies involved?
The case concerns infant health because cereulide can be dangerous for babies, and lawmakers say it also exposed weaknesses in food-safety oversight, official controls and communication during a cross-border product recall Reuters,Le Parisien,Sciences et Avenir.
Where Left and Right agree, and where they split
- Where Left and Right agree
- A contamination scare involving infant formula exposed failures in oversight and recall handling, with a parliamentary review finding that under-resourced authorities relied too heavily on manufacturers’ own checks while key questions about health impact and delays remain unresolved.
- Where Left and Right split
- Less a disagreement than a question of emphasis: the structural imbalance created when regulators depend on company self-checks, versus the broader breakdown of institutional and corporate responsibility once contamination spread across multiple manufacturers and countries.
How left and right read it
The most consequential finding is not just that infant formula contamination posed particular risks for infants, but that a parliamentary review found shortcomings by both manufacturers and the state. Its warning that limited resources pushed control authorities to rely more on companies’ own checks points to a basic imbalance in oversight, with unresolved questions still hanging over health impacts and possible delays in alerts or recalls.
What stands out here is a breakdown in basic oversight: a French parliamentary report said limited resources pushed control authorities toward greater reliance on manufacturers’ own checks, even as Nestle and Danone now face renewed scrutiny over recall handling. When contaminated formula linked to a shared supplier spread across multiple manufacturers and countries, unresolved questions about delays and health impact became a test of whether institutions and firms were meeting their responsibilities.
The receipts — 42 sources
Wire services (6)
Independent coverage (36)
The news, read by both sides.
The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.